Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes
Journal of Cutaneous Pathology · 2025-04 · 52 (4) · 309-316
DOI: 10.1111/cup.14782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, online erschienen am 06.01.2025. Verfasst von Erol Can Bayraktar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Dermatology, NYU Langone Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Transcriptome, Genomics, Adenocarcinoma, Papillary, Sweat Gland Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: University of Texas MD Anderson Cancer Center, NIH HHS, NYU Langone Medical Center.
Abstract (Originalsprache)
Background
Digital papillary adenocarcinoma (DPAC) is a rare but aggressive cutaneous malignant sweat gland neoplasm that occurs on acral sites. Despite its clinical significance, the cellular and genetic characteristics of DPAC remain incompletely understood.
Methods
We conducted a comprehensive genomic and transcriptomic analysis of DPAC ( n = 14) using targeted next‐generation DNA and RNA sequencing, along with gene expression profiling employing the Nanostring Technologies nCounter IO 360 Panel. Gene expression in DPAC was compared to that in hidradenoma ( n = 10). Immunohistochemistry was employed to validate gene expression.
Results
Two out of eight DPACs showed fusion gene rearrangements ( CRTC3 :: MAML2 and TRPS1 :: PLAG1 ). No uniform mutational signature was detected in DPAC. Comparative gene expression analysis revealed an enrichment of genes related to matrix remodeling, metabolism, and DNA damage repair. Hallmark pathway analysis demonstrated significant upregulation of E2F target genes in DPAC compared to hidradenoma ( p = 0.00710). Human papillomavirus‐42 was found to be positive in all of our tested DPAC cases. Immunohistochemistry confirmed increased protein expression of CD56, CDC20, and SOX10 in DPAC. Notably, most DPAC tumors also exhibited B‐cell infiltration, as indicated by CD20 staining.
Conclusions
Our findings reveal novel fusions and validate altered replication pathways related to HPV42 in DPAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Dermatology, NYU Langone Medical Center, New York, New York, USA.
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Erol Can Bayraktar, Phyu P Aung, Pavandeep Gill, Guomiao Shen, Varshini Vasudevaraja, Zongshan Lai, Luis Chiriboga, Doina Ivan, Priyadharsini Nagarajan, Jonathan L Curry, Carlos A Torres-Cabala, Victor G Prieto, George Jour
Förderung
- University of Texas MD Anderson Cancer Center
- NIH HHS
- NYU Langone Medical Center
- Melanoma Research Alliance
- National Institutes of Health
Zitieren
APA
Bayraktar, E. C., Aung, P. P., Gill, P., Shen, G., Vasudevaraja, V., Lai, Z., Chiriboga, L., Ivan, D., Nagarajan, P., Curry, J. L., Torres-Cabala, C. A., Prieto, V. G., & Jour, G. (2025). Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes. Journal of Cutaneous Pathology, 52(4), 309-316. https://doi.org/10.1111/cup.14782
Vancouver
Bayraktar EC, Aung PP, Gill P, Shen G, Vasudevaraja V, Lai Z, et al. Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes. Journal of Cutaneous Pathology. 2025;52(4):309-316. doi:10.1111/cup.14782
BibTeX
@article{Bayraktar2025,
author = {Bayraktar, Erol Can and Aung, Phyu P and Gill, Pavandeep and Shen, Guomiao and Vasudevaraja, Varshini and Lai, Zongshan and Chiriboga, Luis and Ivan, Doina and Nagarajan, Priyadharsini and Curry, Jonathan L and Torres-Cabala, Carlos A and Prieto, Victor G and Jour, George},
title = {Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes},
journal = {Journal of Cutaneous Pathology},
year = {2025},
volume = {52},
number = {4},
pages = {309--316},
doi = {10.1111/cup.14782}
}
EUVIMED